Relationships between sex hormone levels in men over 50 years of age and body composition, bone quality, and quality of life

Nieschlag, 2005, Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations, Eur Urol, 48, 1, 10.1016/j.eururo.2005.04.027 Kyle, 2001, Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years, Eur J Clin Nutr, 55, 663, 10.1038/sj.ejcn.1601198 Bhasin, 1997, Age-associated sarcopenia—issues in the use of testosterone as an anabolic agent in older men, J Clin Endocrinol Metab, 82, 1659, 10.1210/jc.82.6.1659 Orwoll, 1995, Osteoporosis in men, Endocr Rev, 16, 87, 10.1210/edrv-16-1-87 Daniell, 1997, Osteoporosis after orchiectomy for prostate cancer, J Urol, 157, 439, 10.1016/S0022-5347(01)65165-6 Rapado, 1999, Bone mineral density and androgen levels in elderly males, Calcif Tissue Int, 65, 417, 10.1007/s002239900726 Dacal, 2006, Quality of life in prostate cancer patients taking androgen deprivation therapy, J Am Geriatr Soc, 54, 85, 10.1111/j.1532-5415.2005.00567.x Van den Beld, 2000, Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men, J Clin Endocrinol Metab, 85, 3276, 10.1210/jc.85.9.3276 Alonso, 1998, Valores poblacionales de referencia de la versión española del cuestionario de salud MOS SF-36, Med Clin (Barc), 111, 410 Morley, 2001, Sarcopenia, J Lab Clin Med, 137, 231, 10.1067/mlc.2001.113504 Roy, 2002, Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men, Am J Physiol Endocrinol Metab, 283, E284, 10.1152/ajpendo.00334.2001 Vermeulen, 1999, Testosterone, body composition and aging, J Endocrinol Invest, 225, 110 Snyder, 1999, Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age, J Clin Endocrinol Metab, 84, 2647, 10.1210/jc.84.8.2647 Emmelot-Vonk, 2008, Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial, JAMA, 299, 39, 10.1001/jama.2007.51 Couillard, 2000, Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE family study, J Clin Endocrinol Metab, 85, 1026, 10.1210/jc.85.3.1026 Seidell, 1990, Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels, Metabolism, 39, 897, 10.1016/0026-0495(90)90297-P Kaufman, 1997, Declining gonadal function in elderly men, Baillières Clin Endocrinol, 11, 189 Agren, 1991, Ultrasound attenuation of the calcaneus: a sensitive and specific discriminator of osteopenia in postmenopausal women, Calcif Tissue Int, 48, 240, 10.1007/BF02556374 Khosla, 1998, Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen, J Clin Endocrinol Metab, 83, 2266, 10.1210/jc.83.7.2266 Kuchuk, 2007, The association of sex hormone levels with quantitative ultrasound, bone mineral density, bone turnover and osteoporotic fractures in older men and women, Clin Endocrinol (Oxf), 67, 295, 10.1111/j.1365-2265.2007.02882.x Szulc, 2001, Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study, J Clin Endocrinol Metab, 86, 192, 10.1210/jc.86.1.192 Fukui, 2007, Association between serum testosterone concentration and collagen degradation fragments in men with type 2 diabetes mellitus, Metabolism, 56, 1228, 10.1016/j.metabol.2007.04.020 Finas, 2006, Quality of life in elderly men with androgen deficiency, Andrologia, 38, 48, 10.1111/j.1439-0272.2006.00684.x Salminen, 2004, Associations between serum testosterone fall and cognitive function in prostate cancer patients, Clin Cancer Res, 10, 7575, 10.1158/1078-0432.CCR-04-0750 Katznelson, 2006, Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men, Eur J Endocrinol, 155, 867, 10.1530/eje.1.02291 Sánchez-Cruz, 2003, Male erectile dysfunction and health-related quality of life, Eur Urol, 44, 245, 10.1016/S0302-2838(03)00215-X Heinemann, 2006, Sensitivity as outcome measure of androgen replacement: the AMS scale, Health Qual Life Outcomes, 30, 23, 10.1186/1477-7525-4-23 Flaherty, 2004, Anti-aging, Clin Geriatr Med, 20, xi, 10.1016/S0749-0690(04)00027-8 Arlt, 2004, Dehydroepiandrosterone and ageing, Best Pract Res Clin Endocrinol Metab, 18, 363, 10.1016/j.beem.2004.02.006